Table 3. PCR and microbiological results for patients with monkeypox in Marseille during the 2022 outbreak in southern France*.
| Variable | Positive samples/total (%) | Mean Ct (SD) |
|---|---|---|
| PCR results | ||
| Skin swabs | 69/84 (82) | 28.3 (4.7) |
| Genital swabs | 67/69 (97) | 26.2 (4.0) |
| Throat swabs | 50/116 (43) | 32.2 (3.4) |
| Rectal swabs |
68/105 (65) |
26.1 (5.2) |
| Concurrent STIs | ||
| HIV | 2/9 (22.2) | NA |
| Chlamydia trachomatis | 4/127 (3.1) | NA |
| Neisseria gonorrhoeae | 13/127 (10.2) | NA |
| Mycoplasma genitalium | 1/127 (0.8) | NA |
| Syphilis | 4/127 (3.1) | NA |
| Trichomonas vaginalis | 1/127 (0.8) | NA |
| Other STIs | 19/127 (15) | NA |
*Ct, cycle threshold; STI, sexually transmitted infection; NA, not applicable.